Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuo Shioi

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Journal of Molecular and Cellular Cardiology|October 2, 2007
Resistin, an adipocytokine, offers protection against acute myocardial infarctionJinping Gao, Chu Chang Chua, Zhongyi Chen, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 7, 2011
Inter- and intra-observer variability for assessment of the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) score and association of the SYNTAX score with clinical outcome in patients undergoing unprotected left main stenting in the real worldHiroki Shiomi, Toshihiro Tamura, Shunichiro Niki, et al.
Circulation. Heart Failure|February 24, 2010
Analysis of metabolic remodeling in compensated left ventricular hypertrophy and heart failureTakao Kato, Shinichiro Niizuma, Yasutaka Inuzuka, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 3, 2011
Impact of diabetes on cardiovascular outcomes in hemodialysis patients undergoing coronary revascularizationMasahiro Natsuaki, Yutaka Furukawa, Takeshi Morimoto, et al.
Molecular and Cellular Biology|July 1, 2004
Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophyJulie R McMullen, Tetsuo Shioi, Li Zhang, et al.
Cardiovascular Research|February 13, 2008
Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanismTuanzhu Ha, Fang Hua, Xiang Liu, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 6, 2009
Phosphoinositide 3-kinase Akt signaling pathway interacts with protein kinase Cbeta2 in the regulation of physiologic developmental hypertrophy and heart functionDebra L Rigor, Natalya Bodyak, Soochan Bae, et al.
Journal of Molecular and Cellular Cardiology|October 4, 2011
Constitutive SIRT1 overexpression impairs mitochondria and reduces cardiac function in miceTsuneaki Kawashima, Yasutaka Inuzuka, Junji Okuda, et al.
The Journal of Biological Chemistry|November 5, 2003
The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathwayJulie R McMullen, Tetsuo Shioi, Weei-Yuarn Huang, et al.
Free Radical Biology & Medicine|November 22, 2005
Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFkappaB activation in vivoTuanzhu Ha, Yuehua Li, Xiang Gao, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Journal of Molecular and Cellular Cardiology|October 2, 2007
Resistin, an adipocytokine, offers protection against acute myocardial infarctionJinping Gao, Chu Chang Chua, Zhongyi Chen, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 7, 2011
Inter- and intra-observer variability for assessment of the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) score and association of the SYNTAX score with clinical outcome in patients undergoing unprotected left main stenting in the real worldHiroki Shiomi, Toshihiro Tamura, Shunichiro Niki, et al.
Circulation. Heart Failure|February 24, 2010
Analysis of metabolic remodeling in compensated left ventricular hypertrophy and heart failureTakao Kato, Shinichiro Niizuma, Yasutaka Inuzuka, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 3, 2011
Impact of diabetes on cardiovascular outcomes in hemodialysis patients undergoing coronary revascularizationMasahiro Natsuaki, Yutaka Furukawa, Takeshi Morimoto, et al.
Molecular and Cellular Biology|July 1, 2004
Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophyJulie R McMullen, Tetsuo Shioi, Li Zhang, et al.
Cardiovascular Research|February 13, 2008
Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanismTuanzhu Ha, Fang Hua, Xiang Liu, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 6, 2009
Phosphoinositide 3-kinase Akt signaling pathway interacts with protein kinase Cbeta2 in the regulation of physiologic developmental hypertrophy and heart functionDebra L Rigor, Natalya Bodyak, Soochan Bae, et al.
Journal of Molecular and Cellular Cardiology|October 4, 2011
Constitutive SIRT1 overexpression impairs mitochondria and reduces cardiac function in miceTsuneaki Kawashima, Yasutaka Inuzuka, Junji Okuda, et al.
The Journal of Biological Chemistry|November 5, 2003
The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathwayJulie R McMullen, Tetsuo Shioi, Weei-Yuarn Huang, et al.
Free Radical Biology & Medicine|November 22, 2005
Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFkappaB activation in vivoTuanzhu Ha, Yuehua Li, Xiang Gao, et al.
Pageof 5